Skip to main content

Borgeson John A.'s Form 4 filing

Kodiak Sciences Inc.KOD · filed Apr 2, 2026

Accession no.
0001754045-26-000002
Filed
Apr 2, 2026
Trade date
Apr 2, 2026
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.20M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Borgeson John A.CIK 0001754045Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 2, 2026Common StockMOption exerciseAcquired+30,000$1.04+$31,200213,316Direct
Apr 2, 2026Common StockSSaleDisposed−12,692$39.14F2−$496,764.88200,624Direct
Apr 2, 2026Common StockSSaleDisposed−12,477$40.29F3−$502,698.33188,147Direct
Apr 2, 2026Common StockSSaleDisposed−4,231$40.88F4−$172,963.28183,916Direct
Apr 2, 2026Common StockSSaleDisposed−600$41.77F5−$25,062183,316Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 2, 2026Common StockMOption exerciseDisposed−30,000$0.00$058,614Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $38.68 to $39.67, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $39.68 to $40.67, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $40.68 to $41.67, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $41.69 to $41.91, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)